CLHRF Stock UPDATES Coral Gold Res New (CLHRF) 0.1553 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Coral Gold Res New (CLHRF) 0.1553 $CLHRF

Coral Gold Resources New Option Agreement with Barrick Gold, CEO Clip Video
Newsfile Corp - Tue Jul 22, 4:00PM CDT
full story)

Coral Gold Announces Barrick Core Drill Program Has Commenced at Gold Ridge Property, Nevada
Marketwire - Thu Jun 26, 7:03AM CDT
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) ("Coral" or the "Company" is pleased to announce that Barrick commenced the 2014 diamond core hole drill program on June 26, 2014 on the Gold Ridge property located in Crescent Valley, Nevada.

Coral Gold Resources Ltd. : Corporate Communications Agreement, Stock Options, Shares for Debt
Marketwire - Fri Mar 14, 7:39PM CDT
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) ("Coral" or the "Company" announces that it has entered into an agreement with Nancy Massicotte to provide Corporate Communications services. Ms. Massicotte will be responsible for communicating with the investment community, including liaising with the Company's shareholders and prospective shareholders.

Coral Announces Closing of Private Placement and Conditional Acceptance of Option and Joint Venture Agreement
Marketwire - Thu Mar 13, 7:02AM CDT
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) ("Coral" or the "Company" is pleased to announce that, pursuant of its news release dated March 5, 2014, the Company has closed its non-brokered private placement. The Company raised gross proceeds of $705,500 through the issuance of 4,150,000 common shares at a price of C$0.17 per common share. The proceeds of the Private Placement will be used for exploration and for general working capital.

Coral Gold Resources Enters Into Option, Joint Venture and Private Placement with Barrick - Video News Alert on InvestmentPitch.com
Newsfile Corp - Thu Mar 06, 2:48PM CST
full story)

Coral Gold Resources (TSXV:CLH) (OTCBB:CLHRF) (FSE:GV8) Enters Into Option, Joint Venture and Private Placement with Barrick - Video News Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Mar 06, 9:23AM CST
Vancouver, BC, March 6, 2014 - Coral Gold Resources (TSXV:CLH) (OTCBB:CLHRF) (FSE:GV8) has entered into an exploration and option to joint venture agreement on its Gold Ridge Property in Nevada with Barrick Gold. The agreement, which for legal reasons, is officially between Coral Gold, Coral Resources, Barrick Gold Exploration and Barrick Gold Corporation, grants Barrick Gold an option to earn up to an undivided 60% interest in Coral's Gold Ridge Property, in consideration for Barrick Gold incurring US$12 million in exploration expenditures over a five year period.

IIROC Trading Resumption - CLH
CNW Group - Wed Mar 05, 11:17AM CST
Trading resumes in:

Coral Enters Into Option and Joint Venture Agreement and Private Placement of $705,500 With Barrick
Marketwire - Wed Mar 05, 10:24AM CST
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8); ("Coral" or the "Company" is pleased to announce that the Company has entered into an exploration and option to joint venture agreement (the "Option Agreement" with Coral Resources, Inc., the Company's wholly owned subsidiary, Barrick Gold Exploration Inc. ("Barrick Gold" , and Barrick Gold Corporation ("Barrick" , pursuant to which Barrick Gold has been granted an option to earn up to an undivided 60% interest on the Company's Gold Ridge Property in Nevada (consisting of a portion of the Robertson Property) in consideration for Barrick Gold incurring US$12,000,000 in exploration expenditures over a five year period. In addition, Barrick Gold has the option to increase its interest by an additional 15% for an aggregate undivided 75% interest by preparing and delivering to the Company a scoping study. The Option Agreement also provides that upon Barrick Gold exercising its option, a 60%/40% or a 75%/25% joint venture between the parties will be established in order to further explore the Gold Ridge Property.

IIROC Trading Halt - CLH
CNW Group - Wed Mar 05, 7:15AM CST
The following issues have been halted by IIROC:

Coral Receives Approval of Amended Plan of Operation for Robertson Property from Nevada Bureau of Mining Regulation and Reclamation (BMRR)
Marketwire - Mon Jan 13, 7:02AM CST
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) ("Coral" or the "Company" is pleased to announce that its US subsidiary Coral Resources Inc. has received notice from the Bureau of Mining Regulation and Reclamation (BMRR) of the State of Nevada that it has approved the Plan of Amendment for Coral Resources Inc.'s Robertson Project. The BMRR has sent the revised Reclamation Permit to Coral.

Coral Gold Resources Ltd.: Warrants Extension
Marketwire - Wed Sep 18, 1:53PM CDT
Coral Gold Resources Ltd. ("Coral" (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) wishes to announce that it has applied for a third amendment to its terms of the warrants issued pursuant to a private placement announced on March 3, 2010. The first amendment extended the expiry dates of the warrants for six months from April 1, 2012 and April 23, 2012 to October 1, 2012 and October 23, 2012. The current amendment will extend the expiry date of the warrants for a term of one year from October 1, 2013 and October 23, 2013 to October 1, 2014 and October 23, 2014 respectively. All other terms remain the same.

Coral Gets Green Light from US Bureau of Land Management
Marketwire - Mon Sep 16, 7:03AM CDT
Coral Gold Resources Ltd. (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) (the "Company" is pleased to announce that its US subsidiary Coral Resources Inc. has received a notice from the US Bureau of Land Management ("BLM" which includes the Decision on the Robertson Project Amendment to the Exploration Plan of Operations ("A-EPO" and Reclamation Permit Application and also the Finding of No Significant Impact ("FONSI"

Coral Gold Announces Amendment to and Close of Private Placement
Marketwire - Wed Jul 03, 4:52PM CDT
Coral Gold Resources Ltd. (the "Company" (TSX VENTURE: CLH)(OTCBB: CLHRF)(BERLIN: GV8)(FRANKFURT: GV8) announces that the non-brokered private placement (the "Offering" announced on May 30, 2013 has been re-priced to $0.10 per Unit, and that it has raised aggregate proceeds of $369,450 through the sale of 3,694,500 Units. Each Unit consists of one common share and one common share purchase warrant (the "Warrants" exercisable at a price of $0.15 per warrant for a period of 24 months. In the event that, after four months and one day after the closing of the Offering, the volume weighted average trading price of the Company's common shares on the TSX Venture Exchange, exceeds C$0.30 for a period of 15 consecutive trading days, the Company may, after such event, provide notice to the warrant holders of early expiry and thereafter, the Warrants will expire on the date which is 30 days after the date of notice to warrant holders.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading